Licensed programs · Science from Aneira Pharma
Hair Growth
Two clinical-development programs: scalp and eyebrow.Shared follicle-biology science.Focused on pattern hair loss and eyebrow density.
Global pharmaceutical innovation in medical aesthetics
Redefiningregenerative aesthetics.
ObNowa Pharma is a global pharmaceutical company headquartered in Warsaw, Poland, developing science-driven treatments across medical aesthetics and hair growth. We combine innovative science, rigorous clinical development and global development standards with a clear focus on meaningful outcomes for patients and physicians. Our portfolio brings together complementary programs originating from Object Pharma and Aneira Pharma.
Who we are
One company.Complementary science.Global development.
ObNowa Pharma brings together complementary pharmaceutical programs in hair growth and neurotoxin-based medical aesthetics. Headquartered in Warsaw, Poland, we combine European pharmaceutical development capabilities with science and expertise originating from Object Pharma and licensed programs from Aneira Pharma.
Science from Object Pharma
Neurotoxins
Bio-comparable program — established performance standards.Bio-better program — differentiated characteristics.Next-generation aesthetic neurotoxin development.
Our manifesto
Science starts the journey.
Evidence guides development.
Patients define the purpose.
We develop selectively, follow the evidence and keep patients at the centre of every program.
Development pipeline
A focused development portfolio.
All programs are development-stage and investigational. No ObNowa Pharma candidate has been approved by the EMA or any regulatory authority.
Market potential
Demand is growing. Science must keep pace.
Global demand for professional aesthetic treatments continues to grow, creating a need for therapies backed by rigorous pharmaceutical development and clinical evidence. ObNowa was created to help meet that need — together with scientific, clinical and commercial partners who share our commitment to evidence.
€0B+
Projected global medical-aesthetics market by 2030, per published industry analyses
0
Development programs across two areas of scientific focus
0
Origins of science — Object Pharma and Aneira Pharma
Investor relations
Market figures reflect published third-party industry analyses. Nothing here constitutes an offer of securities or investment advice.
Global perspective
Global by design. Grounded in science.
Headquartered in Warsaw, Poland, ObNowa brings together international science, leadership and pharmaceutical development expertise within a global development model. Our programs are advanced to global and EU regulatory standards, with geographic strategies shaped by individual product rights and opportunities.
Work with us
Together, let's develop the newgeneration of aesthetic medicine.
Licensing, clinical development, manufacturing, commercial and scientific partnerships — every route begins with a conversation.